Blood thickens during exercise in rare disorder, study aims to find why
NCT ID NCT07341048
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at why people with polycythemia vera (PV), a rare blood disorder that makes too many red blood cells, often struggle with exercise. Researchers will measure blood thickness and oxygen levels in 54 patients during a treadmill stress test. The goal is to see if a big jump in blood thickness during exercise limits how much oxygen the body can use, which could explain exercise intolerance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors understand why exercise is hard for PV patients and design safer, more effective exercise plans.
- What could go wrong
- This is a small, early observational study (54 people) that only measures effects during one exercise test. It won't test any treatment, so it may not lead to direct improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Sports Medicine and Physical Activity. Pulmonary Function Testing. Croix Rousse Hospital.
Lyon, 69001, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted drug outperform standard care for rare blood cancers?
- Blood pressure pill may tame thick blood disorder
- New drug ZE74-0282 targets rare blood cancers in early trial
- New hope for rare blood cancers: first human trial of PRT12396 begins
- Hunting the gene behind blood disorders
- New Pill-and-Shot combo aims to tame thick blood